Potential use of repetitive transcranial magnetic stimulation in treating pediatric avoidant/restrictive food intake disorder: a case report

重复经颅磁刺激治疗儿童回避/限制性食物摄入障碍的潜在应用:病例报告

阅读:1

Abstract

BACKGROUND: Avoidant/Restrictive Food Intake Disorder (ARFID) is a heterogeneous eating disorder that typically manifests during adolescence, potentially leading to various health issues, such as malnutrition, developmental delays, and psychological disturbances. Currently, the management of ARFID is multidisciplinary, involving dietary modifications, pharmacological treatments, and psychotherapy, but no standardized treatment protocol exists. Repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation technique, has shown promise in treating various psychiatric disorders. However, its application in ARFID treatment remains under-explored. CASE REPORT: This case study presents a 5-year-old boy diagnosed with ARFID and severe malnutrition, who underwent adjunctive low-frequency rTMS therapy. The patient received 1 Hz rTMS stimulation targeting the right dorsolateral prefrontal cortex, with a single session consisting of 1,200 pulses administered once daily for 11 consecutive days. After 11 sessions of TMS treatment, when evaluated using the clinical global impression-improvement scale, the patient was scored 2 points, indicating a moderate improvement in symptoms. Twelve days after hospital admission, the patient exhibited significant improvements in emotional status and eating behavior, and no adverse reactions were observed. Subsequently, the patient was discharged from the hospital. Within two months post-discharge, the patient's body weight was restored and remained stable throughout the one-year follow-up period. CONCLUSION: This case report offers preliminary evidence regarding the application of low-frequency rTMS directed at the right dorsolateral prefrontal cortex as a potential therapeutic approach for childhood ARFID. Our findings add to the burgeoning body of literature on rTMS therapy for ARFID and lend support to the effectiveness and safety of low-frequency rTMS as a treatment modality for childhood ARFID.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。